KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Raw Materials (2016 - 2019)

NovoCure's Raw Materials history spans 6 years, with the latest figure at $3.4 million for Q2 2019.

  • For Q2 2019, Raw Materials rose 36.2% year-over-year to $3.4 million; the TTM value through Jun 2019 reached $3.4 million, up 36.2%, while the annual FY2018 figure was $870000.0, 79.65% down from the prior year.
  • Raw Materials for Q2 2019 was $3.4 million at NovoCure, up from $1.5 million in the prior quarter.
  • Across five years, Raw Materials topped out at $5.9 million in Q3 2017 and bottomed at $870000.0 in Q4 2018.
  • The 5-year median for Raw Materials is $3.6 million (2015), against an average of $3.6 million.
  • The largest annual shift saw Raw Materials skyrocketed 568.82% in 2015 before it plummeted 79.65% in 2018.
  • A 5-year view of Raw Materials shows it stood at $3.5 million in 2015, then surged by 49.03% to $5.2 million in 2016, then fell by 18.44% to $4.3 million in 2017, then tumbled by 79.65% to $870000.0 in 2018, then surged by 294.37% to $3.4 million in 2019.
  • Per Business Quant, the three most recent readings for NVCR's Raw Materials are $3.4 million (Q2 2019), $1.5 million (Q1 2019), and $870000.0 (Q4 2018).